E-Mail
IMAGE: Shareholder value at the end of 2016 compared to IPO for biotech companies and paired controls completing IPOs 1997-2016. Net growth in shareholder value, and the fraction of companies generating. view more
Credit: Center for Integration of Science and Industry, Bentley University
Investing in biotech companies may not entail higher risk than investing in other sectors, according to a new report from Bentley University s Center for Integration of Science and Industry. A large scale study of biotechnology companies that completed Initial Public Offerings (IPOs) from 1997-2016 demonstrates that these companies produced more than $100 billion in shareholder value and almost $100 billion in new value creation despite a failure rate greater than 50%. The study compared the financial performance and economic value created by these biotech companies to non-biotechnology controls that had similarly timed IPOs.
player Jul 20, 2018
He may not have the height, but this new player certainly has the strength and the heart to join Worcester Polytechnic Institute’s men’s basketball team. Boston-headquartered national nonprofit Team IMPACT, whose mission is to improve the quality of life for children facing serious and chronic illnesses through the power of team, along with WPI Men’s Basketball, held a special draft.
Fitzgerald initially began doing temporary work in one of the two milk powder plants at the Darfield site, but when production at the cream cheese plant increased he applied for a permanent role. The plant at Darfield is now operating around the clock to meet the demand, having added 75 per cent more capacity. Plant manager Blake Aston said demand had grown by more than 100 per cent in the last year and five new permanent employees were needed to work the new shifts. China s changing demographics were driving the popularity of Western foods including huge demand for cream cheese which was used in items like lollipops, drinks and moon cakes, Aston said.